Niying Li, Rupesh Panchal, Theodoros Giannouchos, Raymond J Pan, Danielle Nguyen, Robert Nohavec, Laura Britton, Nathorn Chaiyakunapruk, Joseph Biskupiak, Adam Wilson, Diana Brixner
BACKGROUND: Insulin affordability is a huge concern for patients with diabetes in the United States. On March 30, 2020, Utah signed House Bill 207 into law, aimed at capping copayments for insulin at $30 for a 30-day supply. The bill was enacted on January 1, 2021. OBJECTIVE: To assess patient basal insulin adherence, out-of-pocket costs, health plan costs, total costs on insulin, and hemoglobin A1c (A1c) in prepolicy vs postpolicy periods. METHODS: This study is a retrospective analysis using data from a regional health plan in Utah from October 1, 2019, to September 30, 2021...
February 3, 2024: Journal of Managed Care & Specialty Pharmacy